· Venture Capital Tracker · investment-strategies · 2 min read
TAM, SAM, SOM: How to Size a Market the Way VCs Actually Want
TAM, SAM, and SOM — total, serviceable, and obtainable market — define market size for VC diligence. Here's how to compute each without hand-waving.
Market sizing is often where pitches collapse. VCs want to see that you understand TAM, SAM, and SOM and can defend each with real logic — not an analyst report headline.
TAM — Total Addressable Market
The total revenue opportunity if your product captured 100% of the market globally.
- Calculated as: Total target customer count × average revenue per customer.
- Used to show the upper bound of ambition.
SAM — Serviceable Addressable Market
The portion of TAM reachable given product, geography, language, regulatory constraints, and GTM.
- Calculated as: TAM filtered by your realistic serving constraints.
- Examples: SMB vs enterprise, US-only initially, English-only.
SOM — Serviceable Obtainable Market
The share of SAM you can realistically capture in the near term.
- Calculated as: SAM × realistic market share (often 1–10% in a meaningful timeframe).
- Used to show the near-term revenue ceiling at current GTM.
Top-down vs bottom-up
Top-down (discouraged):
- “IDC says the market is $200B. We’ll take 1%.”
- Weak because IDC numbers rarely map to your monetization.
Bottom-up (preferred):
- “There are 50,000 mid-market manufacturers in North America.”
- “Our ACV is $50K/year.”
- “SAM = 50,000 × $50K = $2.5B.”
- “Realistic 5-year SOM at ~3% market share = $75M ARR.”
Investors trust bottom-up because it’s defensible and falsifiable.
Worked example: Vertical SaaS for veterinary clinics
Bottom-up:
- 32,000 veterinary clinics in the U.S.
- ACV: $12,000/year on average.
- TAM (US) = 32,000 × $12K = $384M.
- Global expansion:
4x over 5–10 years → **$1.5B global TAM**. - SAM: 20,000 clinics using cloud software = $240M.
- SOM: 5% share over 5 years = $12M ARR.
A VC will weigh this against the team’s realistic growth rate and category defensibility.
Red flags in market sizing
- “$1 trillion market” without any grounded customer logic.
- Stacked adjacencies: “Healthcare + life sciences + pharmaceuticals + adjacent” — too broad.
- Consumer markets without ARPU math.
- No path to SOM — handwaving “we’ll take 1%” without sales motion.
How top VCs stress-test market size
- Customer interviews: “How much do you pay today for the problem?”
- Bottom-up counts: From industry directories, census data, or vertical associations.
- Comparable company revenues: What do category leaders actually earn?
- Pricing sensitivity: Would a 2x price change market size meaningfully?
Practical takeaway
- Founders: Build your TAM/SAM/SOM from customer counts and ACV, then compare to top-down for sanity.
- Investors: Ignore consultant-report numbers; pressure-test bottom-up logic instead.
- Operators: Refresh market sizing annually — market maturity changes the “realistic SOM” calculation.
Further reading
- NVCA model documents: https://nvca.org/model-legal-documents/
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.